Abstract
Get full access to this article
View all access options for this article.
References
1.
Williams
CD
Linch
DC
. Interferon alfa-2a . Br J Hosp Med
1997 ;57 :436 –9 .
2.
Talpaz
M
Kantarjian
HM
McCredie
K
Keating
MJ
Gutterman
JU
. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia . N Engl J Med
1986 ;314 :1065 –9 .
3.
Mandelli
F
Avvisati
G
Amadori
S
Boccadoro
M
Gernone
A
Laula
VM
Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy . N Engl J Med
1990 ;322 :1430 –4 .
4.
Borden
EC
Parkinson
D
, eds. Side effects of interferon-alpha: Possible clinical causes and intervention strategies . Semin Oncol
1998 ;25 (suppl 1 ):1 –81 .
5.
Kirkwood
JM
Ernsthoff
MS
Davis
CA
Reiss
M
Ferraresi
R
Rudnick
SA
. Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers . Ann Intern Med
1985 ;103 :32 –6 .
6.
Janssen
HLA
Berk
L
Vermeulen
M
Schalm
SW
. Seizures associated with low-dose α-interferon (letter) . Lancet
1990 ;336 :1580 .
7.
Miller
VS
Zwiener
RJ
Fielman
BA
. Interferon-associated refractory status epilepticus . Pediatrics
1994 ;93 :511 –2 .
8.
Shakil
AO
Di Bisceglie
AM
Hoofnagle
JH
. Seizures during alpha interferon therapy . J Hepatol
1996 ;24 :48 –51 .
9.
Woynarowski
M
Socha
J
. Seizures in children during interferon alpha therapy (letter) . J Hepatol
1997 ;26 :956 –7 .
10.
Waltz
S
Christen
HJ
Doose
H
. The different patterns of photoparoxysmal response — A genetic study . Electroenceph Clin Neurophysiol
1992 ;83 :138 –45 .
11.
Calvet
MC
Gresser
I
. Interferon enhances the excitability of cultured neurones . Nature
1979 ;278 :558 –60 .
12.
Blalock
JE
Smith
EM
. Human leukocyte interferon (HulFN-α): Potent endorphin-like opioid activity . Biochem Biophys Res Commun
1981 ;101 :472 –8 .
13.
Guyer
DR
Tiedeman
J
Yannuzzi
LA
Slakter
JS
Parke
D
Kelley
J
Interferon-associated retinopathy . Arch Ophthalmol
1993 ;111 :350 –6 .